149 related articles for article (PubMed ID: 3321494)
1. [Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study].
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ; Rössner M
Vasa Suppl; 1987; 20():375-8. PubMed ID: 3321494
[No Abstract] [Full Text] [Related]
2. [Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental].
Tonak J; Knecht H; Groitl H
Med Monatsschr; 1977 Oct; 31(10):467-72. PubMed ID: 337089
[No Abstract] [Full Text] [Related]
3. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Dtsch Med Wochenschr; 1987 May; 112(22):873-8. PubMed ID: 3556133
[TBL] [Abstract][Full Text] [Related]
4. [Training by walking and drug therapy of peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
[No Abstract] [Full Text] [Related]
5. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of arterial diseases with trental 400. Results of a double-blind study].
Völker D
Med Welt; 1978 Aug; 29(32):1244-7. PubMed ID: 672594
[No Abstract] [Full Text] [Related]
7. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
8. [Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration].
Koshkin VM; Adil'khanov SG; Antonova NIu
Vestn Khir Im I I Grek; 1979 Dec; 123(12):56-60. PubMed ID: 524688
[TBL] [Abstract][Full Text] [Related]
9. On the assessment of the efficacy of pentoxifylline (Trental).
Rössner M; Müller R
J Med; 1987; 18(1):1-15. PubMed ID: 3298515
[TBL] [Abstract][Full Text] [Related]
10. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
Trübestein G; von Bary S; Breddin K; Diehm C; Gruss JD; Heinrich H; Horsch S; Kriessmann A; Maass U; Martin M
Vasa Suppl; 1989; 28():44-9. PubMed ID: 2692200
[TBL] [Abstract][Full Text] [Related]
11. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
von Westphalen JG
MMW Munch Med Wochenschr; 1977 Jul; 119(26):901-4. PubMed ID: 408616
[TBL] [Abstract][Full Text] [Related]
12. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
Hepp W; von Bary S; Corovic D; Diehm C; Mühe E; Rudofsky G; Scheffler P; Trübestein G; Vogelpohl M
Vasa Suppl; 1991; 33():348-9. PubMed ID: 1788753
[No Abstract] [Full Text] [Related]
13. Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
Trübestein G; Trübestein R; Duong QD
Angiology; 1981 Oct; 32(10):705-10. PubMed ID: 7034591
[TBL] [Abstract][Full Text] [Related]
14. Controlled clinical trial of pentoxifylline versus cinnarizine in the treatment of labyrinthine disorders.
Ganança MM; Mangabeira Albernaz PL; Caovilla HH; Ito YI
Pharmatherapeutica; 1988; 5(3):170-6. PubMed ID: 3283777
[TBL] [Abstract][Full Text] [Related]
15. Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin.
Accetto B
Am Heart J; 1982 May; 103(5):864-9. PubMed ID: 7041579
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
[TBL] [Abstract][Full Text] [Related]
17. [Clinical pharmacology of vasoactive substances: study on pentoxifylline].
Pupita F; Rotatori P; Frausini G
Ric Clin Lab; 1981; 11 Suppl 1():293-302. PubMed ID: 7188116
[No Abstract] [Full Text] [Related]
18. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
Billett HH; Kaul DK; Connel MM; Fabry ME; Nagel RL
Nouv Rev Fr Hematol (1978); 1989; 31(6):403-7. PubMed ID: 2694097
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of arterial diseases. A study with Trental 400].
Tannenberg G
Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]